Past Event

Tackling antimicrobial resistance (AMR)

Pathological microbes are increasingly resistant to antimicrobial treatments. The resulting health crisis is one of the greatest challenges facing society. At this event, Jim O'Neill will present the Independent Review on Antimicrobial Resistance and a panel will discuss how to tackle drug resistance.

Date: July 14, 2016, 12:30 pm Innovation & Competition Policy Tags & Topics

Summary

See below for video and presentation.

The medical community has identified antimicrobial resistance as a major issue for human beings. In fact, drug resistance poses a threat to our future development and prosperity, as well as to our health. According to recent studies, the number of deaths attributable to AMR in 2050 could equal 10 million. The figure is alarming, making the estimated number of AMR deaths larger than the amount of victims attributable to cancer (8.2 million in 2050).

Because of its relevance, the AMR must also be treated as an economic issue, and the Review on Antimicrobial Resistance commissioned by the UK government in 2014 is playing a key role for this purpose. A ten-point plan has been developed in the Review for tackling AMR, with public awareness being on top of the list, since the problem is ignored in our society. In order to fight the issue, information campaigns should be carried out, as most people appear to have no clue of what antimicrobial resistance is and why it represents a huge threat. A rise in public awareness towards antimicrobial resistance would also bring results, if people proactively react to it. In fact, a way to reduce the impact of the problem is increasing sanitation and hygiene, which could be done by individuals and constitutes the most effective way of facing the issue.

The plan to tackle AMR suggests to stop using antibiotics in agriculture, environment and food processing. To this extent, more transparency from food producers and retailers and in the whole agricultural sector is needed. In general, our society has to increase surveillance on how antibiotics are used in these fields as well as in medicine. The reduction in use and prescriptions of antibiotics would limit the evolution of bacteria. Rapid and efficient diagnostics could also help: sometimes antibiotics are not useful in medical treatments, and the abuse in prescriptions can only worsen the issue. Antibiotics should only be prescribed if a diagnostic technique is used to prove to the necessity of their use. As an alternative, the medical community should boost the role of vaccines, which would partly reduce the use of antibiotics.

On the research side, new drugs should be developed, both to treat patients with pharmaceutical products other than antibiotics and to tackle antimicrobial resistance directly. However, this also requires an increase in investments in research and global innovation funding: funds from a multiplicity of international stakeholders should be allocated and spent on research in a coordinated and strategic way. It is important to emphasize that action to tackle AMR should be conducted on a global basis, and support to achieve international agreements on what has to be done is needed.

Just committing resources, however, does not lead to the solution of the problem itself. Efforts from policy makers can play a central role. The scarce attention of policy makers to date regarding AMR can be attributed to the low level of information and a missing economic quantification of the problem, both of which would increase the awareness of policy-makers towards it. Moreover, the European Commission also needs directives to clarify which roles it could play as a stakeholder and policy-maker and how it can act in order to influence global action.

As a final remark, we should keep in mind that if we are able, as a global society, to build up an effective and sustainable model for funding research, the issue of AMR can be handled and its impact reduced.

Event notes by Domenico Favoino, Research Assistant

VIDEO RECORDING


Event Materials

The Review on Antimicrobial Resistance: global solutions to drug-resistant infections | Presentation by Jim O’Neill

 

DSC_0773
DSC_0774
DSC_0772
DSC_0783
DSC_0771

Speakers

Anderson IMG

James Anderson

Head of Corporate Government Affairs, GlaxoSmithKline

Davies IMG

Sally Davies

Chief Medical Officer for England

Knirsch IMG

Charles Knirsch

Vice President, Therapeutic Vaccines Program Lead, Vaccine Clinical Research and Development, Pfizer

Jim O‘Neill

Jim O‘Neill

Xavier Prats Monne photo

Xavier Prats Monné

Director General, DG Health and Food Safety (SANTE), European Commission

Karen E. Wilson

Karen E. Wilson

Senior Fellow

Location & Contact

Bruegel, Rue de la Charité 33, 1210 Brussels

Matilda Sevón

Matilda Sevon

matilda.sevon@bruegel.org

Read article More on this topic More by this author

Podcast

Podcast

Unlocking the potential of innovation

Innovation is a hot topic in Europe. But how can its potential be used to the fullest, and what are the challenges in doing that?

By: Bruegel Topic: Innovation & Competition Policy Date: November 8, 2016
Read about event More on this topic

Past Event

Past Event

Europe Lab: Competitiveness and inclusive growth

The Europe Lab aims to support the design, launch and implementation of actionable agendas for public-private collaborations to increase competitiveness and inclusive growth in Europe.

Topic: Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: October 12, 2016
Read about event More on this topic

Past Event

Past Event

The impact of the EU regulatory framework for financial services

At this event Jonathan Hill will discuss the results of the European Commission consultation on the EU regulatory framework for financial services

Speakers: Jonathan Hill, Gerhard Schick, Kay Swinburne and Guntram B. Wolff Topic: Finance & Financial Regulation Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: July 12, 2016
Read about event More on this topic

Past Event

Past Event

Does the euro area need a sovereign insolvency mechanism?

The sovereign debt crisis shook the Euro to its foundations. It soon became clear that there was no mechanism to allow a tidy insolvency of a state wishing to remain inside the euro area. To face future crises, does the EU need a sovereign insolvency mechanism?

Speakers: Jochen Andritzky, Lars Feld, Zsolt Darvas and Guntram B. Wolff Topic: European Macroeconomics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: July 12, 2016
Read about event More on this topic

Past Event

Past Event

Policies for digital innovation

We were pleased to welcome Paul Misener, Vice President of Global Public Policy at Amazon.com, to discuss innovation and regulation.

Speakers: Eva Chamizo, Paul Misener, Stephan Raes, Reinhilde Veugelers and Bruegel Topic: Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: July 11, 2016
Read article More on this topic More by this author

Blog Post

Jérémie Cohen-Setton

The breakdown of productivity diffusion

The OECD has been pushing the idea that the productivity slowdown is not so much due to a lack of innovation but rather due to a lack of innovation diffusion between firms.

By: Jérémie Cohen-Setton Topic: Innovation & Competition Policy Date: June 27, 2016
Read about event More on this topic

Past Event

Past Event

China-Russia relations and their impact on Europe

The economic ties between China and Russia are growing. How will this relation affect Europe?

Speakers: Marek Dabrowski, Zsolt Darvas, Alicia García-Herrero, Vasily Gavrilov, Eric Girardin, Matteo Governatori, Iikka Korhonen, Heli Simola, Laura Solanko, Mingxi Sun and Jianwei Xu Topic: Global Economics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: June 21, 2016
Read about event More on this topic

Past Event

Past Event

European banking supervision: the first eighteen months

After its first 18 months, how has the SSM affected the European banking system?

Speakers: Mario Nava, Dirk Schoenmaker, Nicolas Véron, Pieter Verheugd and Guntram B. Wolff Topic: Finance & Financial Regulation Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: June 14, 2016
Read about event More on this topic

Past Event

Past Event

The Spanish financial crisis: Lessons for the European banking union

Spain is among the countries still recovering from the financial crisis. While misjudged investments were part of the cause, these past mistakes could offer lessons for the European banking union.

Speakers: Miguel Otero-Iglesias, Federico Steinberg, Pia Hüttl, Stefano Neri and Bruegel Topic: Finance & Financial Regulation Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: June 9, 2016
Read about event More on this topic

Past Event

Past Event

Internet taxation: challenges and policy recommendations

As the economy moves online, it becomes more difficult for national tax authorities to collect revenue. How great is the impact, and what should corporate taxation look like in the digital age?

Speakers: Francis Bloch, Caroline Edery, Dmitri Jegorov, Helena Kiurusalmi, J. Scott Marcus and Georgios Petropoulos Topic: Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: June 7, 2016
Read about event

Past Event

Past Event

New perspectives for economic cooperation with Iran

The lifting of international sanctions will have a big impact on the economic relationship between Iran and the rest of the world.

Speakers: Benjamin Godel, Zahra Jazayeri, Mohsen Pakparvar, Simone Tagliapietra, HE Peiman Seadat, Farhad Sharif and Guntram B. Wolff Topic: Energy & Climate, Global Economics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: June 2, 2016
Read about event

Past Event

Past Event

State Aid evaluation: two years of implementation

This event discussed the evaluation of state aid and how it can contribute to better policy-making.

Speakers: Gert-Jan Koopman, Pantelis Koutroumpis, Nicola Pesaresi, Theo Roelandt, Otto Toivanen, Reinhilde Veugelers and Georg Zachmann Topic: Energy & Climate, Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: May 30, 2016
Load more posts